Gyre Therapeutics (GYRE) Interest Expenses (2010 - 2024)
Gyre Therapeutics (GYRE) reported Interest Expenses of $315000.0 for Q1 2024, down 51.01% year-over-year from $643000.0 in Q2 2023, and down 51.01% quarter-over-quarter from $643000.0 in Q1 2023.
Gyre Therapeutics (GYRE) Interest Expenses (2010 - 2024) Analysis & Trends
Gyre Therapeutics (GYRE) has 10 years of Interest Expenses data on file, last reported at $315000.0 in Q1 2024.
- Interest Expenses for Q1 2024 came in at $315000.0, down 51.01% year-over-year; the trailing twelve-month figure through Dec 2024 was $315000.0 (down 51.01% YoY), and the FY2023 annual result was $2.6 million, up 88.79% from the prior year.
- Interest Expenses eased to $315000.0 in Q1 2024 per GYRE's latest filing, from $643000.0 in the prior quarter.
- Over five years, Interest Expenses peaked at $643000.0 in Q1 2023 and troughed at $7000.0 in Q3 2020.
- A 3-year average of $259000.0 and a median of $193000.0 in 2020 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2020 and 2024: Interest Expenses surged 308.82% in 2020, then tumbled 51.01% in 2024.
- A 3-year view of Interest Expenses shows it stood at $71000.0 in 2020, then soared by 805.63% to $643000.0 in 2023, then slumped by 51.01% to $315000.0 in 2024.
- Business Quant data shows GYRE's Interest Expenses at $315000.0 in Q1 2024, $643000.0 in Q1 2023, and $71000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Gyre Therapeutics | 554.75 Mn | 540.62 Mn | 8.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 315,000.00 |
| Mar 31, 2024 | 315,000.00 |
| Mar 31, 2023 | 643,000.00 |
| Mar 31, 2023 | 643,000.00 |
| Dec 31, 2020 | 71,000.00 |
| Dec 31, 2020 | 71,000.00 |
| Sep 30, 2020 | 7,000.00 |
| Sep 30, 2020 | 7,000.00 |
| Dec 31, 2019 | -34,000.00 |
| Dec 31, 2019 | -34,000.00 |
| Dec 31, 2015 | 1.38 Mn |
| Dec 31, 2015 | 1.38 Mn |
| Jun 30, 2015 | 39,000.00 |
| Jun 30, 2015 | 39,000.00 |
| Dec 31, 2014 | 3,000.00 |
| Dec 31, 2014 | 3,000.00 |
| Sep 30, 2014 | 5,000.00 |
| Sep 30, 2014 | 5,000.00 |
| Jun 30, 2014 | 6,000.00 |
| Jun 30, 2014 | 6,000.00 |